{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:30:43Z","timestamp":1793363443821,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004605","name":"Zhengzhou University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004605","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK092485"],"award-info":[{"award-number":["DK092485"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1604284"],"award-info":[{"award-number":["U1604284"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.redox.2019.101275","type":"journal-article","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T02:26:46Z","timestamp":1563330406000},"page":"101275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"special_numbering":"C","title":["GSK3\u03b2-mediated Keap1-independent regulation of Nrf2 antioxidant response: A molecular rheostat of acute kidney injury to chronic kidney disease transition"],"prefix":"10.1016","volume":"26","author":[{"given":"Minglei","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce","family":"Flickinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak K.","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance D.","family":"Dworkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangsuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.redox.2019.101275_bib1","doi-asserted-by":"crossref","first-page":"ITC66","DOI":"10.7326\/AITC201711070","article-title":"Acute kidney injury","volume":"167","author":"Levey","year":"2017","journal-title":"Ann. Intern. Med."},{"issue":"10084","key":"10.1016\/j.redox.2019.101275_bib2","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0140-6736(17)31329-6","article-title":"Management of patients at risk of acute kidney injury","volume":"389","author":"Vanmassenhove","year":"2017","journal-title":"Lancet"},{"issue":"9887","key":"10.1016\/j.redox.2019.101275_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(13)60647-9","article-title":"Acute kidney injury: an increasing global concern","volume":"382","author":"Lameire","year":"2013","journal-title":"Lancet"},{"issue":"9987","key":"10.1016\/j.redox.2019.101275_bib4","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/S0140-6736(15)60126-X","article-title":"International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology","volume":"385","author":"Mehta","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.redox.2019.101275_bib5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ki.2013.153","article-title":"Raising awareness of acute kidney injury: a global perspective of a silent killer","volume":"84","author":"Lewington","year":"2013","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.redox.2019.101275_bib6","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.2215\/CJN.00710113","article-title":"N. Acute kidney injury advisory group of the American society of, world incidence of AKI: a meta-analysis","volume":"8","author":"Susantitaphong","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.redox.2019.101275_bib7","first-page":"85","article-title":"Acute kidney injury: definition, pathophysiology and clinical phenotypes","volume":"37","author":"Makris","year":"2016","journal-title":"Clin. Biochem. Rev."},{"issue":"4","key":"10.1016\/j.redox.2019.101275_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.semnephrol.2016.05.005","article-title":"The role of acute kidney injury in chronic kidney disease","volume":"36","author":"Hsu","year":"2016","journal-title":"Semin. Nephrol."},{"issue":"2","key":"10.1016\/j.redox.2019.101275_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrneph.2012.280","article-title":"Chronic kidney disease following acute kidney injury-risk and outcomes","volume":"9","author":"Leung","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"issue":"8","key":"10.1016\/j.redox.2019.101275_bib10","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1681\/ASN.2015010006","article-title":"Failed tubule recovery, AKI-CKD transition, and kidney disease progression","volume":"26","author":"Venkatachalam","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.redox.2019.101275_bib11","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.kint.2017.06.030","article-title":"AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms","volume":"92","author":"He","year":"2017","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.redox.2019.101275_bib12","doi-asserted-by":"crossref","first-page":"F1078","DOI":"10.1152\/ajprenal.00017.2010","article-title":"Acute kidney injury: a springboard for progression in chronic kidney disease","volume":"298","author":"Venkatachalam","year":"2010","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"5","key":"10.1016\/j.redox.2019.101275_bib13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nrneph.2015.3","article-title":"Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD","volume":"11","author":"Ferenbach","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"issue":"2","key":"10.1016\/j.redox.2019.101275_bib14","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/j.2040-4603.2012.tb00431.x","article-title":"Pathophysiology of acute kidney injury","volume":"2","author":"Basile","year":"2012","journal-title":"Comp. Physiol."},{"issue":"5","key":"10.1016\/j.redox.2019.101275_bib15","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1681\/ASN.2015070740","article-title":"Acute dialysis quality initiative, cellular and molecular mechanisms of AKI","volume":"27","author":"Agarwal","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.redox.2019.101275_bib16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nm.2144","article-title":"Epithelial cell cycle arrest in G2\/M mediates kidney fibrosis after injury","volume":"16","author":"Yang","year":"2010","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.redox.2019.101275_bib17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/ndt\/gfu230","article-title":"Cell cycle arrest and the evolution of chronic kidney disease from acute kidney injury","volume":"30","author":"Canaud","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"issue":"11","key":"10.1016\/j.redox.2019.101275_bib18","doi-asserted-by":"crossref","first-page":"F1187","DOI":"10.1152\/ajprenal.00425.2014","article-title":"Hypoxia as a key player in the AKI-to-CKD transition","volume":"307","author":"Tanaka","year":"2014","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.redox.2019.101275_bib19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.redox.2015.01.001","article-title":"Oxidative stress and autophagy: crucial modulators of kidney injury","volume":"4","author":"Sureshbabu","year":"2015","journal-title":"Redox Biol"},{"issue":"12","key":"10.1016\/j.redox.2019.101275_bib20","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1089\/ars.2016.6804","article-title":"The kidney: an organ in the front line of oxidative stress-associated pathologies","volume":"25","author":"Gorin","year":"2016","journal-title":"Antioxidants Redox Signal."},{"issue":"20","key":"10.1016\/j.redox.2019.101275_bib21","doi-asserted-by":"crossref","first-page":"13291","DOI":"10.1074\/jbc.R900010200","article-title":"The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress","volume":"284","author":"Nguyen","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.redox.2019.101275_bib22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.molmed.2004.09.003","article-title":"Nrf2-Keap1 defines a physiologically important stress response mechanism","volume":"10","author":"Motohashi","year":"2004","journal-title":"Trends Mol. Med."},{"issue":"33","key":"10.1016\/j.redox.2019.101275_bib23","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.2174\/0929867324666170511120814","article-title":"Targeting Nrf2 in protection against renal disease","volume":"24","author":"Guerrero-Hue","year":"2017","journal-title":"Curr. Med. Chem."},{"issue":"6","key":"10.1016\/j.redox.2019.101275_bib24","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/ki.2012.439","article-title":"Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease","volume":"83","author":"Ruiz","year":"2013","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.redox.2019.101275_bib25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1105351","article-title":"Bardoxolone methyl and kidney function in CKD with type 2 diabetes","volume":"365","author":"Pergola","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.redox.2019.101275_bib26","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/ndt\/gft202","article-title":"Nrf2 implicated as a novel therapeutic target for renal regeneration after acute kidney injury","volume":"28","author":"Fledderus","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.redox.2019.101275_bib27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.abb.2014.12.012","article-title":"The Keap1-Nrf2 system and diabetes mellitus","volume":"566","author":"Uruno","year":"2015","journal-title":"Arch. Biochem. Biophys."},{"issue":"37","key":"10.1016\/j.redox.2019.101275_bib28","doi-asserted-by":"crossref","first-page":"26071","DOI":"10.1074\/jbc.274.37.26071","article-title":"Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene","volume":"274","author":"Alam","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.redox.2019.101275_bib29","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bcp.2012.11.016","article-title":"The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation","volume":"85","author":"Bryan","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.redox.2019.101275_bib30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.freeradbiomed.2011.11.003","article-title":"Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: role of glycogen synthase kinase-3","volume":"52","author":"Rojo","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"Pt B","key":"10.1016\/j.redox.2019.101275_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2015.04.029","article-title":"Structural and functional characterization of Nrf2 degradation by glycogen synthase kinase 3\/beta-TrCP","volume":"88","author":"Cuadrado","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2019.101275_bib32","doi-asserted-by":"crossref","first-page":"36698","DOI":"10.1038\/srep36698","article-title":"Rescue therapy with Tanshinone IIA hinders transition of acute kidney injury to chronic kidney disease via targeting GSK3beta","volume":"6","author":"Jiang","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.redox.2019.101275_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/labinvest.2010.142","article-title":"Conditional ablation of glycogen synthase kinase 3beta in postnatal mouse kidney","volume":"91","author":"Ge","year":"2011","journal-title":"Lab. Investig."},{"issue":"10","key":"10.1016\/j.redox.2019.101275_bib34","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1016\/j.ajpath.2014.06.027","article-title":"Glycogen synthase kinase 3beta dictates podocyte motility and focal adhesion turnover by modulating paxillin activity: implications for the protective effect of low-dose lithium in podocytopathy","volume":"184","author":"Xu","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"12","key":"10.1016\/j.redox.2019.101275_bib35","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1097\/01.ASN.0000098686.72971.DB","article-title":"Hepatocyte growth factor modulates matrix metalloproteinases and plasminogen activator\/plasmin proteolytic pathways in progressive renal interstitial fibrosis","volume":"14","author":"Gong","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.redox.2019.101275_bib36","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/ki.2011.443","article-title":"Inhibition of glycogen synthase kinase-3beta prevents NSAID-induced acute kidney injury","volume":"81","author":"Bao","year":"2012","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.redox.2019.101275_bib37","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1074\/jbc.M710396200","article-title":"Hepatocyte growth factor suppresses proinflammatory NFkappaB activation through GSK3beta inactivation in renal tubular epithelial cells","volume":"283","author":"Gong","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"37","key":"10.1016\/j.redox.2019.101275_bib38","doi-asserted-by":"crossref","first-page":"39493","DOI":"10.18632\/oncotarget.6303","article-title":"The redox sensitive glycogen synthase kinase 3beta suppresses the self-protective antioxidant response in podocytes upon oxidative glomerular injury","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.redox.2019.101275_bib39","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/ki.2008.380","article-title":"Candesartan suppresses chronic renal inflammation by a novel antioxidant action independent of AT1R blockade","volume":"74","author":"Chen","year":"2008","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.redox.2019.101275_bib40","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1681\/ASN.2015050565","article-title":"Genetic and pharmacologic targeting of glycogen synthase kinase 3beta reinforces the Nrf2 antioxidant defense against podocytopathy","volume":"27","author":"Zhou","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.redox.2019.101275_bib41","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.freeradbiomed.2007.10.055","article-title":"Keap1 modification and nuclear accumulation in response to S-nitrosocysteine","volume":"44","author":"Buckley","year":"2008","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.redox.2019.101275_bib42","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1053\/j.ajkd.2015.06.026","article-title":"Remote ischemic preconditioning for kidney protection: GSK3beta-centric insights into the mechanism of action","volume":"66","author":"Liu","year":"2015","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"10.1016\/j.redox.2019.101275_bib43","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1476-5381.2009.00284.x","article-title":"Inhibiting glycogen synthase kinase-3 reduces endotoxaemic acute renal failure by down-regulating inflammation and renal cell apoptosis","volume":"157","author":"Wang","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.redox.2019.101275_bib44","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.pnpbp.2008.08.012","article-title":"Lithium: bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium","volume":"32","author":"Marmol","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.redox.2019.101275_bib45","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrneph.2009.43","article-title":"Lithium nephrotoxicity revisited","volume":"5","author":"Grunfeld","year":"2009","journal-title":"Nat. Rev. Nephrol."},{"issue":"6","key":"10.1016\/j.redox.2019.101275_bib46","doi-asserted-by":"crossref","first-page":"F1168","DOI":"10.1152\/ajprenal.00145.2016","article-title":"What we need to know about the effect of lithium on the kidney","volume":"311","author":"Gong","year":"2016","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"6","key":"10.1016\/j.redox.2019.101275_bib47","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/ki.2013.248","article-title":"Role of Nrf2 in protection against acute kidney injury","volume":"84","author":"Shelton","year":"2013","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.redox.2019.101275_bib48","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1093\/ndt\/gft022","article-title":"Role of impaired Nrf2 activation in the pathogenesis of oxidative stress and inflammation in chronic tubulo-interstitial nephropathy","volume":"28","author":"Aminzadeh","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.redox.2019.101275_bib49","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ki.2013.343","article-title":"Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-kappaB-mediated inflammatory response","volume":"85","author":"Jiang","year":"2014","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.redox.2019.101275_bib50","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/1568007054038238","article-title":"The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders","volume":"4","author":"van Muiswinkel","year":"2005","journal-title":"Curr. Drug Targets - CNS Neurol. Disord."},{"issue":"9","key":"10.1016\/j.redox.2019.101275_bib51","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.freeradbiomed.2009.07.035","article-title":"Nrf2:INrf2 (Keap1) signaling in oxidative stress","volume":"47","author":"Kaspar","year":"2009","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.redox.2019.101275_bib52","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/ng1248","article-title":"Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation","volume":"35","author":"Wakabayashi","year":"2003","journal-title":"Nat. Genet."},{"issue":"26","key":"10.1016\/j.redox.2019.101275_bib53","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"de Zeeuw","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.redox.2019.101275_bib54","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/ndt\/gfu002","article-title":"Keap1 inhibition attenuates glomerulosclerosis","volume":"29","author":"Miyazaki","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"issue":"6","key":"10.1016\/j.redox.2019.101275_bib55","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1128\/MCB.01204-10","article-title":"SCF\/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner","volume":"31","author":"Rada","year":"2011","journal-title":"Mol. Cell. Biol."},{"issue":"21","key":"10.1016\/j.redox.2019.101275_bib56","doi-asserted-by":"crossref","first-page":"14841","DOI":"10.1074\/jbc.M513737200","article-title":"Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2","volume":"281","author":"Salazar","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.redox.2019.101275_bib57","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/gutjnl-2013-306043","article-title":"Therapeutic targeting of GSK3beta enhances the Nrf2 antioxidant response and confers hepatic cytoprotection in hepatitis C","volume":"64","author":"Jiang","year":"2015","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.redox.2019.101275_bib58","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1111\/j.1600-6143.2008.02319.x","article-title":"Glycogen synthase kinase 3beta: a novel marker and modulator of inflammatory injury in chronic renal allograft disease","volume":"8","author":"Gong","year":"2008","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.redox.2019.101275_bib59","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.etp.2010.08.010","article-title":"Folic acid induces acute renal failure (ARF) by enhancing renal prooxidant state","volume":"64","author":"Gupta","year":"2012","journal-title":"Exp. Toxicol. Pathol."},{"issue":"11","key":"10.1016\/j.redox.2019.101275_bib60","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1097\/CCM.0b013e31822575fc","article-title":"N-acetylcysteine is effective for prevention but not for treatment of folic acid-induced acute kidney injury in mice","volume":"39","author":"Wang","year":"2011","journal-title":"Crit. Care Med."},{"issue":"22","key":"10.1016\/j.redox.2019.101275_bib61","doi-asserted-by":"crossref","first-page":"16502","DOI":"10.1074\/jbc.M611336200","article-title":"GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2","volume":"282","author":"Jain","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2019.101275_bib62","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.freeradbiomed.2013.02.008","article-title":"Regulation of nrf2-an update","volume":"66","author":"Niture","year":"2014","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.redox.2019.101275_bib63","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1681\/ASN.2009080828","article-title":"GSK3beta promotes apoptosis after renal ischemic injury","volume":"21","author":"Wang","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.redox.2019.101275_bib64","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1476-5381.2008.00085.x","article-title":"Glycogen synthase kinase 3: more than a namesake","volume":"156","author":"Rayasam","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"Suppl 1","key":"10.1016\/j.redox.2019.101275_bib65","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.diabres.2007.01.033","article-title":"The role of GSK3 in glucose homeostasis and the development of insulin resistance","volume":"77","author":"Lee","year":"2007","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"26","key":"10.1016\/j.redox.2019.101275_bib66","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.2174\/092986710792065090","article-title":"Using small molecule GSK3beta inhibitors to treat inflammation","volume":"17","author":"Klamer","year":"2010","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.redox.2019.101275_bib67","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0959-4388(02)00320-3","article-title":"The GSK3 beta signaling cascade and neurodegenerative disease","volume":"12","author":"Kaytor","year":"2002","journal-title":"Curr. Opin. Neurobiol."},{"issue":"8","key":"10.1016\/j.redox.2019.101275_bib68","first-page":"931","article-title":"Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice","volume":"8","author":"Singh","year":"2015","journal-title":"Dis Model Mech"},{"issue":"4","key":"10.1016\/j.redox.2019.101275_bib69","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7150\/thno.14334","article-title":"Glycogen synthase kinase-3 (GSK-3)-Targeted therapy and imaging","volume":"6","author":"Pandey","year":"2016","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.redox.2019.101275_bib70","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrd1415","article-title":"GSK3 inhibitors: development and therapeutic potential","volume":"3","author":"Cohen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.redox.2019.101275_bib71","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1124\/mi.4.5.6","article-title":"Molecular effects of lithium","volume":"4","author":"Quiroz","year":"2004","journal-title":"Mol. Interv."},{"issue":"4","key":"10.1016\/j.redox.2019.101275_bib72","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1254\/jphs.CRJ05009X","article-title":"Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases","volume":"99","author":"Wada","year":"2005","journal-title":"J. Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.redox.2019.101275_bib73","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1056\/NEJM197708252970807","article-title":"Lithium carbonate attenuation of chemotherapy-induced neutropenia","volume":"297","author":"Stein","year":"1977","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.redox.2019.101275_bib74","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1681\/ASN.V103666","article-title":"Lithium intoxication","volume":"10","author":"Timmer","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.redox.2019.101275_bib75","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1681\/ASN.2013040350","article-title":"Delayed administration of a single dose of lithium promotes recovery from AKI","volume":"25","author":"Bao","year":"2014","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231719300564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231719300564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:01:05Z","timestamp":1785772865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231719300564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":75,"alternative-id":["S2213231719300564"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2019.101275","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GSK3\u03b2-mediated Keap1-independent regulation of Nrf2 antioxidant response: A molecular rheostat of acute kidney injury to chronic kidney disease transition","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2019.101275","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101275"}}